Company intelligence / Profile preview

Foundation

Cambridge, Massachusetts, United Statesfordfoundation.org ↗

Ownership: Private
Employees: ~1700
Development stage: Other

Overview

Foundation Medicine has commercialized several comprehensive genomic profiling assays for both solid and hematologic cancers. Its tests are widely used in clinical practice and research to guide personalized cancer treatment decisions. The company’s data have contributed significantly to public cancer genomics resources and are integrated into routine care at leading institutions.

Therapeutic areas: Oncology
Modalities: Diagnostic assay (Comprehensive genomic profiling)Next-generation sequencing technology
Industry: Molecular Diagnostics

Partnerships

Novartis and over thirty other biopharma partners for sample analysis and clinical trial support as of pre-acquisition period.Guardant Health IP licensing agreement.

Beyond the preview

Go deeper on Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foundation.

Explore the full profile